家畜の疼痛緩和と予防市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、製品タイプ別、投与経路別、エンドユーザー別、地域別、競合別、2020～2030年

家畜の疼痛緩和と予防の世界市場規模は2024年に563億2,000万米ドルとなり、2030年までのCAGRは9.46%で予測期間中に970億1,000万米ドルに達すると予測されています。

世界の家畜の疼痛緩和と予防市場は、動物福祉に関する意識の高まりと持続可能な農法に対する需要の高まりによって大きな成長を遂げています。世界の畜産業が動物の扱いに関する監視の強化に直面する中、特に生産現場やヘルスケアにおいて、動物の快適性を向上させ、苦痛を軽減することに重点が置かれています。特に先進国市場では、動物虐待に対する消費者の懸念が高まっており、疼痛緩和と予防ソリューションの必要性が高まっています。より良い治療と福祉基準を推進する政府の規制がこの動向をさらに後押しし、家畜の所有者や農家が、家畜の疼痛管理を含め、より人道的な慣行を採用するよう促しています。

動物医療における技術の進歩が、家畜の疼痛緩和市場の拡大に寄与しています。非ステロイド性抗炎症薬（NSAIDs）やオピオイド代替薬などの革新的な疼痛管理製品の開発により、治療効果が向上しています。これらの製品の有効性と安全性を向上させることに重点を置いた調査により、さまざまな動物タイプのニーズに合わせたより専門的な製剤が市場を牽引しています。痛みが畜産動物の重大な福祉問題であるとの認識が広まり、手術中や負傷後、慢性的な症状に対する鎮痛療法の採用が増加しています。このような畜産分野での予防対策へのシフトが、市場の主要促進要因となっています。

このような成長にもかかわらず、市場はさらなる拡大を阻害しかねないいくつかの課題に直面しています。先進的な疼痛緩和治療には高いコストがかかるため、特に小規模農家や新興農家にとっては大きな障壁となっています。さらに、特に開発途上地域の一部の農家では、疼痛予防の重要性に関する認識や教育が不足していることも懸念されます。また、獣医による治療が一貫して受けられないことや、動物タイプによって治療プロトコルが複雑であることも、市場における障害となりうる。新しい疼痛管理製品の承認をめぐる規制上の課題は、市場の状況をさらに複雑にしており、安全性と有効性に関する厳しいガイドラインを満たす必要があります。

主な市場促進要因

高品質の動物用医薬品に対する需要の高まり

動物用医薬品の進歩

畜産業の増加

主な市場課題

疼痛緩和製品の高コスト

獣医療専門家の不足

主な市場動向

天然および有機の疼痛緩和製品に対する需要の高まり

鎮痛・麻酔剤の使用拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の家畜の疼痛緩和と予防市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別（牛、豚、鶏、馬、その他）
  • 製品タイプ別（NSAID、オピオイド、麻酔薬、アルファ2作動薬、コルチコステロイド、局所麻酔薬、その他）
  • 投与経路別（経口、注射、局所、その他）
  • エンドユーザー別（畜産農家、動物病院、調査機関、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の家畜の疼痛緩和と予防市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • メキシコ
  • カナダ

第7章 欧州の家畜の疼痛緩和と予防市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の家畜の疼痛緩和と予防市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の家畜の疼痛緩和と予防市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの家畜の疼痛緩和と予防市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale S.A.
• Virbac S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Farm Animal Pain Relief and Prevention Market was valued at USD 56.32 Billion in 2024 and is expected to reach USD 97.01 Billion in the forecast period with a CAGR of 9.46% through 2030. The Global Farm Animal Pain Relief and Prevention Market is experiencing significant growth driven by the increasing awareness regarding animal welfare and rising demand for sustainable farming practices. As the global livestock industry faces greater scrutiny over animal treatment, there is a stronger emphasis on improving animal comfort and reducing pain, especially in production and healthcare settings. Increasing consumer concerns over animal cruelty, particularly in developed markets, is prompting the need for pain relief and prevention solutions. Government regulations promoting better treatment and welfare standards further support this trend, encouraging livestock owners and farmers to adopt more humane practices, including pain management for farm animals.

Technological advancements in veterinary medicine have contributed to the expansion of the farm animal pain relief market. The development of innovative pain management products, such as non-steroidal anti-inflammatory drugs (NSAIDs) and opioid alternatives, has enhanced the effectiveness of treatments. Research focused on improving the efficacy and safety of these products has driven the market forward, with more specialized formulations tailored to the needs of different animal species. The growing recognition of pain as a significant welfare issue in farm animals has led to increased adoption of pain relief therapies during surgery, after injuries, or for chronic conditions. This shift toward preventive measures in the livestock sector is a key market driver.

Despite this growth, the market faces several challenges that could impede its further expansion. High costs of advanced pain relief treatments remain a significant barrier, particularly for small-scale and emerging farmers who may not have the financial resources to implement these solutions. Additionally, there are concerns over the lack of awareness and education regarding the importance of pain prevention among some farmers, especially in developing regions. The inconsistent availability of veterinary care and the complexity of treatment protocols for different species can also pose hurdles in the market. Regulatory challenges surrounding the approval of new pain management products further complicate the market landscape, with stringent guidelines on safety and efficacy that must be met for widespread adoption.

Key Market Drivers

Growing Demand for High-Quality Animal Products

The growing demand for high-quality animal products is a significant driver for the Global Farm Animal Pain Relief and Prevention Market. As consumer preferences shift towards more humane, ethically produced meat and dairy products, there is an increased focus on animal welfare. Farms are under greater scrutiny to ensure their animals are treated with care and respect throughout their lifecycle, including during periods of pain or distress. Pain management, including the use of effective pain relief and prevention strategies, is becoming a critical aspect of maintaining high standards of animal welfare.

Consumers are more aware of the conditions under which their food is produced, and this has led to a demand for products that are ethically sourced, with minimal stress or discomfort to the animals. This shift is influencing farmers and livestock producers to adopt pain relief measures to prevent unnecessary suffering, especially in animals undergoing routine medical procedures such as vaccinations, castrations, and dehorning. The use of pain relief products not only aligns with animal welfare standards but also improves productivity by reducing the stress levels in animals, leading to better growth, feed conversion, and overall health.As the trend for premium, ethically produced animal products rises, governments and organizations are instituting more rigorous regulations surrounding animal welfare. This is pushing livestock producers to adopt pain relief solutions to comply with emerging standards and enhance the quality of their products. In this way, the growing demand for high-quality animal products serves as a key driver for the expansion of the farm animal pain relief and prevention market, ensuring that animal welfare and product quality go hand in hand.

According to the Food and Agriculture Organization (FAO), global meat consumption is projected to rise by 2% on a per capita basis by 2032, driven by increasing consumer sensitivity to animal welfare, environmental, and health concerns. This trend underscores the importance of adopting pain relief and prevention measures to meet consumer expectations for ethically produced animal products.

In the United States, the Department of Agriculture (USDA) has recognized the importance of organic and ethically produced products, with certified organic U.S. land increasing from 1.8 million acres in 2000 to 4.9 million acres in 2021. This growth reflects a significant shift in consumer demand towards products that adhere to higher animal welfare standards, further driving the need for effective pain management solutions in the livestock industry.

Advancements in Veterinary Pharmaceuticals

Advancements in veterinary pharmaceuticals play a significant role in driving the growth of the Global Farm Animal Pain Relief and Prevention Market. As livestock farming continues to evolve, there has been an increased focus on developing more effective and safer pain relief medications for farm animals. These advancements include the introduction of novel drug formulations and new classes of pain management drugs designed to target specific pain pathways more precisely. Veterinary pharmaceutical companies are increasingly investing in research and development to create drugs that not only alleviate pain but also minimize side effects and improve the overall welfare of farm animals.

For instance, innovations in injectable analgesics and non-invasive pain relief options are gaining traction. These pharmaceutical advancements are being driven by the growing awareness of animal welfare and the need for effective pain management during common agricultural procedures like castration, dehorning, and after surgeries. The demand for drugs that offer prolonged pain relief with fewer doses is also pushing forward the development of sustained-release formulations.

Moreover, the regulatory landscape has been evolving to encourage the development and approval of new veterinary pain management drugs, especially in regions with stringent regulations for animal health. As farmers and veterinarians seek to improve productivity by ensuring their livestock remains healthy and stress-free, advancements in pain relief therapies become essential. These innovations not only provide better outcomes for the animals but also help mitigate potential losses due to animal suffering and prevent longer-term health complications. The ongoing improvement in veterinary pharmaceuticals is likely to continue driving the market for farm animal pain relief and prevention solutions in the coming years.

Increase in Livestock Farming

The increase in livestock farming is a significant driver for the Global Farm Animal Pain Relief and Prevention Market. As the global demand for meat, dairy, and other animal products continues to rise, livestock farming has seen substantial growth. In 2023, the volume of chicken, pig, and cattle-the main meats produced worldwide reached 321 million tonnes. This expansion results in a greater number of animals being raised for consumption, which, in turn, leads to a higher incidence of health issues and pain-related conditions in farm animals.

Farm animals are often subjected to intensive farming practices, including castration, dehorning, and other procedures, which can cause significant pain and stress. These practices highlight the growing need for effective pain relief and prevention solutions. The rise in livestock farming also comes with an increased focus on animal welfare, with more attention being paid to the well-being of animals during their rearing and handling. Regulatory agencies and animal rights organizations are advocating for better pain management protocols, prompting farmers to adopt pain relief products to ensure compliance with ethical standards and improve the overall health of their livestock.

As livestock farming becomes more industrialized, the volume of animals requiring pain relief for medical conditions or post-surgical recovery also increases. Pain relief products, such as NSAIDs, opioids, and local anesthetics, are becoming essential tools in managing the physical health of farm animals. This growing awareness about animal pain and the importance of humane treatment drives demand for advanced pain relief solutions, benefiting the market for farm animal pain relief and prevention products. As livestock farming expands globally, the need for these solutions will continue to rise.

Key Market Challenges

High Costs of Pain Relief Products

High costs of pain relief products represent a significant challenge for the Global Farm Animal Pain Relief and Prevention Market. Many pain relief products, including NSAIDs, opioids, and anesthetics, can be expensive for farmers, particularly in regions with smaller-scale farming operations. These costs can limit the widespread adoption of effective pain management solutions, especially for livestock farmers with tight profit margins. Pain relief products often require regular and consistent administration, adding to the ongoing expenses associated with maintaining livestock health. For farmers, the high initial and ongoing costs of these treatments may deter them from purchasing the most effective or necessary products.

In addition, the financial burden is compounded by the regulatory requirements for veterinary drugs. Pain relief medications often undergo rigorous testing, approval processes, and compliance checks, all of which contribute to higher market prices. Many small and medium-sized farms may struggle to afford these products, leading to a disparity in the availability of pain relief solutions between larger commercial farms and smaller operations. This issue exacerbates the challenge of ensuring that all animals receive proper care and pain management, potentially affecting animal welfare standards.

In some regions, government subsidies or price regulations may mitigate this challenge to a degree, but this is not a universal solution. In such cases, the cost burden still remains on farmers who must decide whether to prioritize animal welfare or manage the financial pressures of running a farm. This cost-related barrier may prevent the widespread adoption of pain relief products, limiting the market's potential for growth.

Lack of Specialized Veterinary Care

One of the major challenges faced by the Global Farm Animal Pain Relief and Prevention Market is the lack of specialized veterinary care. In many regions, especially rural and remote areas, farm animals often do not receive the level of veterinary attention they require for effective pain management. A shortage of veterinarians with expertise in large animal care limits the ability to diagnose and treat pain in farm animals effectively. This is particularly evident in developing economies where veterinary professionals are scarce, and farmers may not have access to advanced pain relief treatments. Without proper pain management, animals may experience prolonged suffering, leading to decreased productivity, lower welfare standards, and even higher mortality rates.

The lack of specialized care also results in an underutilization of pain management products, as many farmers are either unaware of the available treatments or do not have the proper knowledge to administer them safely. This lack of education in pain management practices is further exacerbated by cultural and economic factors, where the priority is often placed on cost-cutting measures rather than ensuring animal welfare. In addition, the inadequate infrastructure and limited access to high-quality veterinary care also impact the market's growth potential in several regions, particularly in low-income areas where farmers rely on general veterinary services rather than specialized pain relief care.

As specialized veterinary care remains limited, efforts to expand education, resources, and services to address animal pain relief will be crucial in overcoming this challenge. The absence of dedicated professionals prevents optimal pain management strategies from being implemented, hindering the growth of the farm animal pain relief and prevention market.

Key Market Trends

Rising Demand for Natural and Organic Pain Relief Products

A significant trend influencing the Global Farm Animal Pain Relief and Prevention Market is the growing demand for natural and organic pain relief products. As consumer awareness of environmental sustainability and animal welfare increases, there is a notable shift towards organic farming practices. According to the U.S. Department of Agriculture (USDA), organic food sales in the United States surpassed USD 60 billion in 2022, marking a 31.7% increase from the previous census. This surge in organic agriculture is accompanied by a rise in certified organic farms, which increased by 5% to 17,445 between 2019 and 2021. These developments reflect a broader consumer preference for products that are both environmentally friendly and ethically produced.

In the veterinary sector, the FDA has approved several natural and organic pain relief products for animals. For instance, in January 2022, the FDA approved Solensia (frunevetmab injection), the first monoclonal antibody treatment for osteoarthritis pain in cats. Such approvals highlight the industry's commitment to providing effective, natural alternatives to traditional pain management solutions.

The increasing consumer demand for organic products, coupled with regulatory support for natural pain relief solutions, is driving the market towards more sustainable and humane practices. This trend is expected to continue, with both consumers and producers favoring natural and organic options in the farm animal pain relief and prevention market.

Expanding Use of Analgesic and Anesthetic Agents

The expanding use of analgesic and anesthetic agents is a significant trend shaping the Global Farm Animal Pain Relief and Prevention Market. As awareness about animal welfare increases, farmers and veterinarians are increasingly focusing on improving pain management practices for farm animals. This shift is driving the adoption of more sophisticated analgesic and anesthetic agents designed to provide effective pain relief during various medical procedures and after injuries or surgeries. Products like NSAIDs, opioids, local anesthetics, and alpha-2 agonists are becoming more widely used in the care of farm animals to manage both acute and chronic pain.

The growing recognition of the need to ensure proper pain management aligns with the changing regulatory landscape. Governments and animal welfare organizations have introduced policies that emphasize the humane treatment of animals, creating a demand for pain management products. For instance, anesthetic agents are frequently used in procedures such as castration, dehorning, and surgical interventions, where pain relief is essential for minimizing stress and discomfort for animals. These products not only improve the quality of life for the animals but also enhance productivity by preventing complications that could arise from untreated pain.

In addition, the increasing focus on improving animal welfare in developed economies, alongside rising awareness in developing regions, is accelerating the growth of this trend. Farmers and veterinarians are increasingly recognizing the long-term benefits of using analgesic and anesthetic agents, such as reduced stress, improved healing times, and better overall health outcomes for animals. This trend is expected to continue, with a shift toward more targeted and effective pain relief methods for farm animals, contributing to the growing market for pain relief and prevention solutions in the coming years.

Segmental Insights

Animal Type Insights

Based on the Animal Type, Cattle emerged as the dominant segment in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to their significant role in global agriculture and the increasing focus on their welfare. Cattle are not only a primary source of milk and meat but also play a central role in the economy of many countries. As a result, there is a heightened awareness of the need to ensure their well-being, especially in relation to pain management during various medical procedures such as dehorning, castration, and calving. These practices often cause substantial pain, making the use of effective pain relief solutions critical for both animal welfare and productivity. The growing adoption of modern veterinary practices also contributes to the dominance of the cattle segment. As farmers and veterinarians become more knowledgeable about the importance of pain management, they are increasingly turning to NSAIDs, anesthetics, and other analgesic agents to mitigate discomfort and prevent long-term health complications. This focus on pain relief enhances cattle health, improves milk and meat production, and reduces the risk of infections or other health issues that could arise from untreated pain. With the increasing recognition of the economic and ethical benefits of pain relief, cattle are expected to remain the dominant segment in this market moving forward.

End User Insights

Based on the End User, Livestock Farmers emerged as the dominant segment in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to their direct involvement in the management of animal health and well-being. As the primary stakeholders in the production of milk, meat, and other animal-based products, livestock farmers are increasingly recognizing the economic and ethical importance of managing pain in farm animals. Effective pain relief not only promotes animal welfare but also enhances the productivity and quality of the products, such as milk and meat, thereby directly benefiting the farm's bottom line. The adoption of pain relief measures by livestock farmers has been influenced by growing awareness of animal welfare regulations and the increasing pressure to ensure humane practices in animal husbandry. The use of pain management solutions such as NSAIDs, local anesthetics, and corticosteroids is crucial during common procedures such as dehorning, castration, and vaccination. Furthermore, livestock farmers are investing in advanced pain relief treatments to reduce the risk of complications, improve recovery rates, and minimize losses in production.

Regional Insights

North America emerged as the dominant region in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to several key factors, including well-established veterinary practices, stringent animal welfare regulations, and a highly developed agricultural sector. The U.S. and Canada have large-scale farming operations where livestock production is a major industry, including cattle, poultry, and pigs. In these countries, the demand for effective pain relief and prevention solutions is high, driven by the need to enhance productivity and ensure the well-being of animals, which are critical to maintaining the quality and quantity of animal-based products. The strong regulatory framework surrounding animal welfare in North America has further spurred the adoption of pain relief solutions. These regulations require farmers to implement humane practices, including the use of analgesics and anesthetics during common procedures such as vaccinations, castrations, and surgical interventions. Additionally, the increasing awareness of the long-term benefits of pain management, such as improved recovery times and higher yields of meat and milk, has contributed to the market's growth. North America's advanced healthcare infrastructure, along with a significant investment in research and development of innovative pain relief solutions, has solidified its position as the dominant region. The availability of both over-the-counter and prescription analgesics, as well as the growing trend of precision livestock farming, further fuels market expansion in the region.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale S.A.
• Virbac S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Ltd.

Report Scope:

In this report, the Global Farm Animal Pain Relief and Prevention Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Farm Animal Pain Relief and Prevention Market, By Animal Type:

• Cattle
• Swine
• Poultry
• Equine
• Others

Farm Animal Pain Relief and Prevention Market, By Product Type:

• NSAIDs
• Opioids
• Anesthetics
• Alpha-2 Agonists
• Corticosteroids
• Local Anesthetics
• Others

Farm Animal Pain Relief and Prevention Market, By Route of Administration:

• Oral
• Injectable
• Topical
• Others

Farm Animal Pain Relief and Prevention Market, By End User:

• Livestock Farmers
• Veterinary Clinics & Hospitals
• Research Institutes
• Others

Farm Animal Pain Relief and Prevention Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Farm Animal Pain Relief and Prevention Market.

Available Customizations:

Global Farm Animal Pain Relief and Prevention Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Farm Animal Pain Relief and Prevention Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Cattle, Swine, Poultry, Equine, Others)
  • 5.2.2. By Product Type (NSAIDs, Opioids, Anesthetics, Alpha-2 Agonists, Corticosteroids, Local Anesthetics, Others)
  • 5.2.3. By Route of Administration (Oral, Injectable, Topical, Others)
  • 5.2.4. By End User (Livestock Farmers, Veterinary Clinics & Hospitals, Research Institutes, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Farm Animal Pain Relief and Prevention Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product Type
  • 6.2.3. By Route of Administration
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End User

7. Europe Farm Animal Pain Relief and Prevention Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product Type
  • 7.2.3. By Route of Administration
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End User

8. Asia-Pacific Farm Animal Pain Relief and Prevention Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product Type
  • 8.2.3. By Route of Administration
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End User
  • 8.3.2. India Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By End User

9. South America Farm Animal Pain Relief and Prevention Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product Type
  • 9.2.3. By Route of Administration
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End User

10. Middle East and Africa Farm Animal Pain Relief and Prevention Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product Type
  • 10.2.3. By Route of Administration
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Boehringer Ingelheim International GmbH
• 14.3. Elanco Animal Health Incorporated
• 14.4. Bayer AG
• 14.5. Neogen Corporation
• 14.6. Merck & Co., Inc.
• 14.7. Ceva Sante Animale S.A.
• 14.8. Virbac S.A.
• 14.9. Vetoquinol S.A.
• 14.10. Norbrook Laboratories Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer